RAPT Therapeutics, Inc.
RAPTDelisted Mar 3, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001673772
RAPT Therapeutics, Inc. was delisted on Mar 3, 2026; its insiders filed their last Form 4 on Mar 5, 2026; 106 institutions reported holding it in 13F filings for Q4 2025, worth $1.02B in total; no superinvestor held it.
13F holders, Q3 2025
Institutional positions in RAPT Therapeutics, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 65
- +15 vs. Q2 2025
- Shares held
- 16.6M
- −365.2K (−2.2%) vs. Q2 2025
- Total value
- $428.0M
- +$292.4M (+215.6%) vs. Q2 2025
- New holders
- 23
- 11 more added
- Sold out
- 8
- 19 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RAPT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 106 | $1.02B |
| Q3 2025 | 65 | $428.0M |
| Q2 2025 | 50 | $135.6M |
| Q1 2025 | 92 | $160.0M |
| Q4 2024 | 91 | $199.5M |
| Q3 2024 | 94 | $59.9M |
| Q2 2024 | 103 | $97.0M |
| Q1 2024 | 122 | $287.2M |
| Q4 2023 | 109 | $869.3M |
| Q3 2023 | 96 | $577.8M |
| Q2 2023 | 98 | $636.7M |
| Q1 2023 | 106 | $610.5M |
| Q4 2022 | 95 | $634.7M |
| Q3 2022 | 98 | $721.0M |
| Q2 2022 | 85 | $542.7M |
| Q1 2022 | 85 | $616.1M |
| Q4 2021 | 99 | $1.02B |
| Q3 2021 | 106 | $817.8M |
| Q2 2021 | 109 | $846.6M |
| Q1 2021 | 78 | $468.4M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding RAPT Therapeutics, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bessemer Group Inc | 11 | $0 | 0.00% | +11 | New |
| SRS Capital Advisors, Inc. | 1 | $25 | 0.00% | +1 | New |
| Point72 (DIFC) Ltd | 16 | $405 | 0.00% | +16 | New |
| Citigroup Inc | 24 | $619 | 0.00% | −2,111−98.9% | Reduced |
| EverSource Wealth Advisors, LLC | 58 | $1.50K | 0.00% | +2+3.6% | Added |
| Fortitude Family Office, LLC | 63 | $1.63K | 0.00% | +63 | New |
| BNP Paribas Arbitrage, SA | 79 | $2.04K | 0.00% | −56−41.5% | Reduced |
| Nisa Investment Advisors, LLC | 79 | $2.04K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 95 | $2.45K | 0.00% | +73+331.8% | Added |
| CWM, LLC | 113 | $3.00K | 0.00% | −589−83.9% | Reduced |
| Banque Cantonale Vaudoise | 154 | $7.00K | 0.00% | +154 | New |
| JPMorgan Chase & Co | 323 | $8.33K | 0.00% | −1−0.3% | Reduced |
| The PNC Financial Services Group, Inc. | 497 | $12.8K | 0.00% | 00.0% | Unchanged |
| Russell Investments Group, Ltd. | 1,080 | $27.9K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 2,699 | $69.6K | 0.00% | +2,699 | New |
| Bank of America Corp | 3,971 | $102.4K | 0.00% | −2,942−42.6% | Reduced |
| Dimensional Fund Advisors LP | 8,934 | $230.6K | 0.00% | +8,934 | New |
| Trustees of Columbia University in the City of New York | 9,172 | $236.5K | 0.04% | +9,172 | New |
| Charles Schwab Investment Management Inc | 10,000 | $257.9K | 0.00% | 00.0% | Unchanged |
| Gsa Capital Partners LLP | 10,558 | $272.0K | 0.02% | −1,586−13.1% | Reduced |
| Point72 Asset Management, L.P. | 12,378 | $319.2K | 0.00% | +12,378 | New |
| AJU IB Investment Co., Ltd. | 12,437 | $320.8K | 0.28% | 00.0% | Unchanged |
| HighTower Advisors, LLC | 12,625 | $325.6K | 0.00% | +12,625 | New |
| Royal Bank of Canada | 14,454 | $373.0K | 0.00% | +16+0.1% | Added |
| Citadel Advisors LLC | 15,530 | $400.5K | 0.00% | +15,530 | New |
| Acadian Asset Management LLC | 16,788 | $432.0K | 0.00% | −74,287−81.6% | Reduced |
| Marshall Wace, LLP | 16,845 | $434.4K | 0.00% | +16,845 | New |
| Northern Trust Corp | 17,020 | $438.9K | 0.00% | −7,719−31.2% | Reduced |
| Bridgeway Capital Management, LLC | 20,625 | $531.9K | 0.01% | +5,000+32.0% | Added |
| Morgan Stanley | 22,096 | $569.9K | 0.00% | +4,082+22.7% | Added |
| UBS Group AG | 28,808 | $743.0K | 0.00% | +25,116+680.3% | Added |
| Renaissance Technologies LLC | 34,311 | $884.9K | 0.00% | −28,162−45.1% | Reduced |
| Superstring Capital Management LP | 34,449 | $888.4K | 0.88% | +8,415+32.3% | Added |
| Two Sigma Investments, LP | 34,818 | $898.0K | 0.00% | −8,803−20.2% | Reduced |
| State Street Corp | 37,383 | $964.1K | 0.00% | +18,321+96.1% | Added |
| Millennium Management LLC | 39,278 | $1.01M | 0.00% | +16,854+75.2% | Added |
| Susquehanna International Group, LLP | 45,382 | $1.17M | 0.00% | +45,382 | New |
| Balyasny Asset Management LLC | 50,348 | $1.30M | 0.00% | +50,348 | New |
| Ameriprise Financial Inc | 51,406 | $1.33M | 0.00% | +51,406 | New |
| Goldman Sachs Group Inc | 61,576 | $1.59M | 0.00% | +39,310+176.5% | Added |
| Velan Capital Investment Management LP | 79,977 | $2.06M | 1.94% | +79,977 | New |
| Euclidean Capital LLC | 82,234 | $2.12M | 0.89% | 00.0% | Unchanged |
| BlackRock, Inc. | 89,503 | $2.31M | 0.00% | −346−0.4% | Reduced |
| SummitTX Capital, L.P. | 91,912 | $2.37M | 0.10% | +91,912 | New |
| Geode Capital Management, LLC | 121,464 | $3.13M | 0.00% | −18,595−13.3% | Reduced |
| Invesco Ltd. | 140,544 | $3.62M | 0.00% | +140,544 | New |
| The Column Group LLC | 166,075 | $4.28M | 5.29% | −1,162,538−87.5% | Reduced |
| Perceptive Advisors LLC | 183,890 | $4.74M | 0.14% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 223,860 | $5.77M | 0.15% | +223,860 | New |
| FMR LLC | 248,378 | $6.41M | 0.00% | +246,442+12,729.4% | Added |
| FCPM III Services B.V. | 344,237 | $8.88M | 1.77% | −95,939−21.8% | Reduced |
| ADAR1 Capital Management, LLC | 507,771 | $13.1M | 1.30% | −275,446−35.2% | Reduced |
| Soleus Capital Management, L.P. | 537,903 | $13.9M | 0.74% | +537,903 | New |
| Redmile Group, LLC | 552,594 | $14.3M | 1.39% | −78,092−12.4% | Reduced |
| Siren, L.L.C. | 580,466 | $15.0M | 0.59% | +580,466 | New |
| Ikarian Capital, LLC | 615,000 | $15.9M | 3.59% | +615,000 | New |
| Nantahala Capital Management, LLC | 623,282 | $16.1M | 0.99% | −328,331−34.5% | Reduced |
| Vanguard Group Inc | 696,188 | $18.0M | 0.00% | −183,861−20.9% | Reduced |
| Deep Track Capital, LP | 751,422 | $19.4M | 0.54% | 00.0% | Unchanged |
| Boone Capital Management LLC | 782,461 | $20.2M | 6.62% | +782,461 | New |
| OrbiMed Advisors LLC | 1,086,618 | $28.0M | 0.67% | −555,288−33.8% | Reduced |
| RTW Investments, LP | 1,470,499 | $37.9M | 0.47% | 00.0% | Unchanged |
| Foresite Capital Management VI LLC | 1,562,500 | $40.3M | 15.57% | 00.0% | Unchanged |
| TCG Crossover Management, LLC | 1,636,275 | $42.2M | 2.08% | 00.0% | Unchanged |
| Medicxi Ventures Management (Jersey) Ltd | 2,794,000 | $72.1M | 9.68% | 00.0% | Unchanged |
| BVF Inc | 0 | $0 | 0.00% | −1,154,692−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −23,673−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −1,918−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −1,229−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −136−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −197−100.0% | Sold out |
| Essential Partners LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −1−100.0% | Sold out |